IL-1β Protects Human Chondrocytes from CD95-Induced Apoptosis

Abstract
This study addresses the effects of IL-1β on apoptosis induced by agonistic anti-CD95 (Fas) Ab. IL-1β inhibited anti-CD95 Ab-induced apoptosis in all preparations of normal human articular chondrocytes tested. Inhibitors of nitric oxide synthase or cyclooxygenase did not influence the protective effect of IL-1β, indicating that nitric oxide and PGs were not involved in the modulation of CD95-induced apoptosis. However, when the IL-1β-dependent induction of NF-κB was inhibited, the antiapoptotic effect of IL-1β was partially reversed, suggesting that NF-κB-mediated gene activation is part of the protective mechanism. In addition, IL-1β significantly increased the expression of Bcl-2. The protein tyrosine kinase inhibitor herbimycin A completely eliminated the protective effect of IL-1β on CD95-induced apoptosis. These findings suggest that IL-1β modulates the CD95 death cascade in chondrocytes by mechanisms that involve tyrosine phosphorylation events and NF-κB-dependent gene activation.